These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 23258845

  • 1. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
    Sung KW, Lim DH, Son MH, Lee SH, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ.
    Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
    [Abstract] [Full Text] [Related]

  • 2. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
    Baek HJ, Park HJ, Sung KW, Lee SH, Han JW, Koh KN, Im HJ, Kang HJ, Park KD.
    J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
    [Abstract] [Full Text] [Related]

  • 3. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
    Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC, Lim DH, Kim HS.
    J Korean Med Sci; 2012 Feb; 27(2):135-40. PubMed ID: 22323859
    [Abstract] [Full Text] [Related]

  • 4. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
    Lee JW, Lim DH, Sung KW, Cho HW, Ju HY, Hyun JK, Yoo KH, Koo HH, Suh YL, Joung YS, Shin HJ.
    Cancer Med; 2020 Aug; 9(16):5807-5818. PubMed ID: 32608158
    [Abstract] [Full Text] [Related]

  • 5. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT.
    Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
    [Abstract] [Full Text] [Related]

  • 6. Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study.
    Lee JW, Lee S, Cho HW, Ma Y, Yoo KH, Sung KW, Koo HH, Cho EJ, Lee SK, Lim DH.
    J Hematol Oncol; 2017 May 16; 10(1):108. PubMed ID: 28511709
    [Abstract] [Full Text] [Related]

  • 7. Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
    Ma Y, Lim DH, Cho H, Lee JW, Sung KW, Yoo KH, Koo HH, Shin HJ, Suh YL.
    J Korean Med Sci; 2020 Dec 14; 35(48):e405. PubMed ID: 33316857
    [Abstract] [Full Text] [Related]

  • 8. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
    Sung KW, Son MH, Lee SH, Yoo KH, Koo HH, Kim JY, Cho EJ, Lee SK, Choi YS, Lim DH, Kim JS, Kim DW.
    Bone Marrow Transplant; 2013 Jan 14; 48(1):68-73. PubMed ID: 22635247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
    Zia MI, Forsyth P, Chaudhry A, Russell J, Stewart DA.
    Bone Marrow Transplant; 2002 Nov 14; 30(9):565-9. PubMed ID: 12407430
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ.
    Lancet Oncol; 2006 Oct 14; 7(10):813-20. PubMed ID: 17012043
    [Abstract] [Full Text] [Related]

  • 13. Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.
    Lee SH, Son MH, Sung KW, Choi YB, Lee NH, Yoo KH, Koo HH, Lim DH, Shin HJ.
    J Neurooncol; 2014 Dec 14; 120(3):507-13. PubMed ID: 25108776
    [Abstract] [Full Text] [Related]

  • 14. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
    Choi JY, Kang HJ, Hong KT, Hong CR, Lee YJ, Park JD, Phi JH, Kim SK, Wang KC, Kim IH, Park SH, Choi YH, Cheon JE, Park KD, Shin HY.
    Int J Clin Oncol; 2019 Dec 14; 24(12):1515-1525. PubMed ID: 31352632
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
    Okada K, Soejima T, Sakamoto H, Hirato J, Hara J.
    Pediatr Blood Cancer; 2020 Nov 14; 67(11):e28572. PubMed ID: 32710713
    [Abstract] [Full Text] [Related]

  • 16. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 17. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
    Lee JW, Lim DH, Sung KW, Lee HJ, Yi ES, Yoo KH, Koo HH, Suh YL, Shin HJ.
    J Korean Med Sci; 2017 Feb 01; 32(2):195-203. PubMed ID: 28049229
    [Abstract] [Full Text] [Related]

  • 18. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U.
    Klin Padiatr; 1998 Feb 01; 210(4):248-55. PubMed ID: 9743961
    [Abstract] [Full Text] [Related]

  • 19. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K, Okada K, Soejima T, Sakamoto H, Hara J.
    Pediatr Blood Cancer; 2020 Jan 01; 67(1):e28012. PubMed ID: 31544362
    [Abstract] [Full Text] [Related]

  • 20. High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Pérez-Martínez A, Quintero V, Vicent MG, Sevilla J, Díaz MA, Madero L.
    J Neurooncol; 2004 Jan 01; 67(1-2):101-6. PubMed ID: 15072454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.